For research use only. Not for therapeutic Use.
Bromperidol (Cat.No:I000253), also known as Bromperidol decanoate, is a butyrophenone derivative and a highly potent antipsychotic drug. It acts as a dopamine receptor antagonist, primarily at the D2 receptor, and is used for the treatment of schizophrenia and other psychotic disorders. It has a long-acting form, decanoate, which is administered via intramuscular injection. Side effects may include extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome.
| CAS Number | 10457-90-6 |
| Molecular Formula | C21H23BrFNO2 |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Solubility | DMSO: 34 mg/mL |
| Storage | Store at -20℃ |
| IUPAC Name | 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one |
| InChI | InChI=1S/C21H23BrFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 |
| InChIKey | RKLNONIVDFXQRX-UHFFFAOYSA-N |
| SMILES | O=C(C1=CC=C(F)C=C1)CCCN2CCC(O)(C3=CC=C(Br)C=C3)CC2 |
